Medplus Health Services Ltd
Medplus Health Services Ltd Company History
Medplus Health Services is in the business of pathological laboratory testing and manufacturing, wholesale trading and contract manufacturing of pharma, fast-moving consumer goods and beauty products and rendering of management services to group companies and holds investments in subsidiary companies.
2007
Pharmaceutica Ventures Limited invested ?800 million, by subscribing to 45,720 equity shares, Peepul Capital Fund II LLC invested ? 226.33 million by subscribing to 30,000 equity shares of the Company and NEA-IndoUS Venture Capital LLC invested $5 million by subscribing to 11,620 equity shares of our Company (out of which 4,662 equity shares through conversion of Series A CCPS.)
2007
2012
EBITDA of our Company turned positive
2012
2017
Gangadi Investments Private Limited acquired 122,347 equity shares, 12,000,000 unlisted redeemable preference shares and 42,847,000 non-convertible debentures from MKCP Direct Investments (Mauritius) IV Limited, MKCP Institutional Investor (Mauritius) III Limited, TVS Shriram Growth Fund IA and Indiaventure Trust  Fund I
2017
2019
PI Opportunities Fund - I invested acquiring 22.21% stake of our Company as on date, pursuant to purchase of 21,233 equity shares
2019
2021
Lavender Rose invested ?6.56 billion, acquiring a 24.58% stake of our Company as on date through primary and secondary transactions.
PI Opportunities Fund - I invested ?222.10 million by subscribing to 160,147 Series C2 CCPS
2021
2023
Medplus Health Services Ltd. got approval from NCL regarding the Scheme of Amalgamation of MHS Pharmaceuticals Private Limited with MedPlus Health Services Limited.
2023
